| 000 | 01652cam a22003977i 4500 | ||
|---|---|---|---|
| 005 | 20250918234731.0 | ||
| 008 | 140529s2013 enka 000 0 eng d | ||
| 020 |
_a9781907568091 _cRM760.38 |
||
| 020 | _a[1907568093] | ||
| 020 | _z9781908818393 (online) | ||
| 039 | 9 |
_a201409241155 _bazhari _c201407221717 _drajak _c201407221705 _drajak _c201407211732 _drajak _y05-29-2014 _zfida |
|
| 040 |
_aNDD _beng _erda _cNDD _dDLC _dBTCTA _dUKMGB _dYDXCP _dCDX _dBDX _dUZ0 _dNLM _dOCLCF _dUKM _erda |
||
| 090 | _aQV736.AA1H557o 2013 9 | ||
| 090 |
_aQV736.AA1 _bH557o 2013 9 |
||
| 100 | 1 |
_aHernberg-Stahl, Elizabeth, _eauthor. |
|
| 245 | 1 | 0 |
_aOrphan drugs : _bunderstanding the rare disease market and its dynamics / _cElizabeth Hernberg-Stahl and Miroslav Reljanovic. |
| 264 |
_aOxford : _bWP, Woodhead Publishing, _c2013. |
||
| 300 |
_axviii, 317 pages : _billustrations ; _c24 cm. |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 490 | 1 |
_aWoodhead publishing series in biomedicine ; _v46 |
|
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 2 |
_aOrphan Drug Production _zUnited States. |
|
| 650 | 2 |
_aDrug Approval _zUnited States. |
|
| 700 | 1 | _aReljanovic, Miroslav. | |
| 830 | 0 |
_aWoodhead Publishing series in biomedicine ; _v46. |
|
| 907 |
_a.b15914732 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQV736.AA1H557o 2013 9 |
||
| 914 | _avtls003560929 | ||
| 990 | _amrt | ||
| 991 | _aFakulti Farmasi, KKL | ||
| 998 |
_ad _b2014-03-05 _cm _da _feng _genk _y0 _z.b15914732 |
||
| 999 |
_c570991 _d570991 |
||